COST OF LONG-ACTING RISPERIDONE INJECTION VERSUS LONG-ACTING PALIPERIDONE PALMITATE IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA

被引：0
作者：
Omelyanovsky, V [1 ]
Avxentyeva, M. [1 ]
Ivakhnenko, O. [1 ]
Khailov, P. [1 ]
Tsfasman, F. M. [1 ]
Krysanov, I [1 ]
Zorin, N. [1 ]
机构：
[1] Russian Natl Res Med Univ, Res Ctr Clin & Econ Evaluat & Pharmacoecon, Moscow, Russia
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A338 / A338
页数：1
相关论文
共 50 条
  • [31] Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia
    Catalan, Rosa
    Penades, Rafael
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 95 - 105
  • [32] Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate
    Joshi, Kruti
    Pan, Xiaoyun
    Wang, Rosa
    Yang, Erru
    Benson, Carmela
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (11) : 1873 - 1881
  • [33] EVALUATION OF PALIPERIDONE PALMITATE LONG-ACTING INJECTABLE THERAPY BY DURATION OF ILLNESS IN PATIENTS WITH SCHIZOPHRENIA
    Brown, B.
    Turkoz, I.
    Mancevski, B.
    Mathews, M.
    Reeve-Parker, K.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 161 - 161
  • [34] Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia
    Brown, Brianne
    Turkoz, Ibrahim
    Mancevski, Branislav
    Mathews, Maju
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 198 - 198
  • [35] Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia
    Brown, Brianne
    Turkoz, Ibrahim
    Mancevski, Branislav
    Mathews, Maju
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 212S - 212S
  • [36] Comparison of treatment retention between risperidone long-acting injection, paliperidone palmitate, and aripiprazole once-monthly in elderly patients with schizophrenia
    Suzuki, Hidenobu
    Hibino, Hiroyuki
    PSYCHOGERIATRICS, 2022, 22 (01) : 159 - 160
  • [37] Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia
    Rosenheck, Robert A.
    Leslie, Douglas L.
    Sint, Kyaw J.
    Lin, Haiqun
    Li, Yue
    McEvoy, Joseph P.
    Byerly, Matthew J.
    Hamer, Robert M.
    Swartz, Marvin S.
    Stroup, T. Scott
    PSYCHIATRIC SERVICES, 2016, 67 (10) : 1123 - 1129
  • [38] The influence of the introduction of paliperidone palmitate long-acting injection on oral prescription of schizophrenic patients
    Uno, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S978 - S978
  • [39] Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
    Alphs, Larry
    Bossie, Cynthia A.
    Sliwa, Jennifer Kern
    Fu, Dong-Jing
    Ma, Yi-Wen
    Hulihan, Joseph
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 341 - 350
  • [40] A randomized, double-blind study of flexible doses of paliperidone palmitate and risperidone long-acting therapy in patients with schizophrenia
    Pandina, G.
    Lane, R.
    Gopal, S.
    Gassmann-Mayer, C.
    Hough, D.
    Remmerie, B.
    Simpson, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 232 - 232
12345